Cell Therapy Manufacturing Market Historical Trends (2022-2023) and Forecasted Estimates (2024-2035)
September 16, 2024 05:12 ET
|
Research and Markets
Dublin, Sept. 16, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market (6th Edition): Industry Trends and Global Forecasts to 2035 - Distribution by Type of Cell Therapy, Source of Cells,...
NMDP℠ Organizes Nationwide Fundraisers to Propel Research, Aid Patients with Blood Cancer and Diseases
September 13, 2024 09:00 ET
|
NMDP
NMDP, a global leader in cell therapy, will host its first-ever community event series, NMDP: Unite to help find cures for blood cancers and diseases.
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
September 12, 2024 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024
September 09, 2024 16:05 ET
|
Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160...
Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
September 06, 2024 07:00 ET
|
https://immatics.com/
Houston, Texas and Tuebingen, Germany, September 06, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the discovery and...
Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule
September 05, 2024 04:00 ET
|
Laverock Therapeutics
STEVENAGE, United Kingdom, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...
Cell Therapy Market Size to Hit USD 28.98 Billion by 2032, Driven by Advances in Personalized Medicine and Stem Cell Applications | SNS Insider
September 04, 2024 09:00 ET
|
SNS Insider pvt ltd
Pune, Sept. 04, 2024 (GLOBE NEWSWIRE) -- “According to SNS Insider, The Cell Therapy Market, valued at USD 4.65 billion in 2023 and is projected to reach USD 28.98 billion by 2032, driven by a...
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024
September 03, 2024 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Senti Bio to Participate in Upcoming Investor Conferences
September 03, 2024 08:15 ET
|
Senti Biosciences, Inc.
Senti Bio will participate in two upcoming investor conferences in September.
CGT Research Outlook Technology Report 2024: Capacity and Capability Expansion for CDMOs, Technology Licensing Partnerships, Shift Towards CGT Development for Chronic Diseases
August 30, 2024 06:46 ET
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "CGT Research Outlook and Technology Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The report covers the...